Key Resolution Details
The company seeks member approval through postal ballot (remote e-voting only) for one special resolution:
Resolution 1: Approval for raising funds up to ₹700 Crore
- Purpose: To raise funds aggregating to ₹700 Crore (Rupees Seven Hundred Crore only) through issuance of securities
- Securities Types: Fully paid-up Equity Shares, fully/partly convertible debentures, non-convertible debentures with warrants, equity-based instruments, or other financial instruments/securities convertible into/linked to Equity Shares
- Methods: Preferential issue(s), private placement(s), qualified institutions placement(s), or any combination thereof
- Tranches: One or more tranches/issuances simultaneously or otherwise
- Investors: Qualified institutional buyers, foreign/resident investors, venture capital funds, alternative investment funds, foreign portfolio investors, financial institutions, non-resident Indians, pension funds, accredited investors
- Pricing: May include discount up to 5% on floor price as per SEBI ICDR Regulations
Fund Utilization
The funds will be utilized for:
- Augmenting long-term cash resources
- Funding organic and inorganic growth opportunities
- Capital expenditure in subsidiaries, network hospitals, and affiliates
- Working capital requirements of the company and its subsidiaries
- Investments in existing/future subsidiaries, joint ventures, and affiliates
- Expansion and modernization initiatives
- Exploration of acquisition opportunities
- Repayment/prepayment of indebtedness
- General corporate purposes
Voting Details
- Cut-off Date: June 12, 2026 (for determining voting eligibility)
- Voting Period: June 19, 2026 (9:00 AM IST) to July 18, 2026 (5:00 PM IST)
- Voting Method: Remote e-voting only through NSDL platform
- Result Declaration: On or before July 20, 2026 (5:00 PM IST)
- Scrutinizer: Ankit Tiwari, Proprietor of Ankit Tiwari & Co., Practicing Company Secretaries
QIP Specific Provisions (If Applicable)
- Allotment only to QIBs as defined in SEBI ICDR Regulations
- Completion within 365 days from shareholder approval
- No allotment to promoters or persons related to promoters
- Minimum 10% allocation to mutual funds
- No single allottee more than 50% of issue size
- Securities under lock-in for one year from allotment date
- Credit rating agency to monitor proceeds utilization
Document Availability
The postal ballot notice is available on:
- Company website: www.artemishospitals.com/investors
- NSDL website: www.evoting.nsdl.com
- BSE website: www.bseindia.com
- NSE website: www.nseindia.com
Shareholder Services
- RTA: Alankit Assignments Limited, New Delhi
- Investor Contact: investor@artemishospitals.com
- e-Voting Support: NSDL at evoting@nsdl.com or 022-48867000
Capital Structure Impact
- Equity shares issued will rank pari-passu with existing shares
- Potential dilution depending on final issue size and pricing
- Exact impact on shareholding pattern not specified as investors not yet identified
Governance Aspects
- Board meeting approval obtained on February 2, 2026
- No director or key managerial personnel is interested in the resolution except to the extent of their shareholding
- No change in control anticipated from the fundraising